Transthyretin Amyloid Cardiomyopathy (ATTR-CM) - American Heart Association Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle As it progresses, the heart can become unable to adequately squeeze to pump blood out of the heart, ultimately leading to heart failure
Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options . . . Abstract Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressively debilitating, rare disease associated with high mortality ATTR-CM occurs when TTR amyloid protein builds up in the myocardium along with different organs, most commonly the peripheral and the autonomic nervous systems
Everything You Need to Know About ATTR-CM - Verywell Health ATTR-CM is a rare medical condition that stands for transthyretin amyloid cardiomyopathy It causes an abnormal accumulation of protein in the heart, which can be fatal if the heart is unable to pump blood effectively throughout the body Jump to Key Takeaways ATTR-CM is a type of restrictive